BFM
TEVA icon

Boston Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History

Boston Financial Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,695
Closed -$262K – 286
2016
Q3 		$262K Sell
5,695
-4,016
-41% -$210K 0.02% 225
2016
Q2 		$488K Sell
9,711
-2,560
-21% -$136K 0.04% 194
2016
Q1 		$657K Sell
12,271
-275
-2% -$16.1K 0.1% 131
2015
Q4 		$824K Sell
12,546
-9,770
-44% -$604K 0.12% 129
2015
Q3 		$1.26M Sell
22,316
-11,590
-34% -$751K 0.18% 124
2015
Q2 		$2M Sell
33,906
-585
-2% -$36.1K 0.26% 112
2015
Q1 		$2.15M Sell
34,491
-30
-0.1% -$1.74K 0.27% 105
2014
Q4 		$1.99M Buy
34,521
+7,455
+28% +$415K 0.25% 110
2014
Q3 		$1.46M Buy
27,066
+760
+3% +$40.3K 0.19% 126
2014
Q2 		$1.38M Buy
26,306
+7,375
+39% +$377K 0.18% 131
2014
Q1 		$1M Buy
18,931
+4,825
+34% +$223K 0.13% 145
2013
Q4 		$565K Sell
14,106
-2,245
-14% -$88.4K 0.08% 156
2013
Q3 		$618K Sell
16,351
-3,135
-16% -$122K 0.09% 150
2013
Q2 		$764K Buy
+19,486
New +$759K 0.12% 143

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Boston Financial Management's TEVA Position: Q4 2016 in Review

Boston Financial Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 5,695 shares — an estimated $262K sold.

Boston Financial Management first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $2.15M in Q1 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Boston Financial Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Boston Financial Management sold 5,695 Teva Pharmaceuticals shares in Q4 2016, an estimated $262K.
  • Boston Financial Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Boston Financial Management's Teva Pharmaceuticals position peaked at $2.15M in Q1 2015.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Boston Financial Management's 13F filing for Q4 2016, filed 10 Feb 2017.